Virpax Change In Cash from 2010 to 2024

VRPX Stock  USD 0.46  0.02  4.17%   
Virpax Pharmaceuticals Change In Cash yearly trend continues to be fairly stable with very little volatility. Change In Cash is likely to outpace its year average in 2024. During the period from 2010 to 2024, Virpax Pharmaceuticals Change In Cash regression line of annual values had significance of  0.76 and arithmetic mean of (92,785). View All Fundamentals
 
Change In Cash  
First Reported
2019-12-31
Previous Quarter
4.6 K
Current Value
-1.9 M
Quarterly Volatility
8.4 M
 
Covid
Check Virpax Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Virpax Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 988 or Interest Expense of 126.5 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.03. Virpax financial statements analysis is a perfect complement when working with Virpax Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of Virpax Pharmaceuticals Correlation against competitors.
For more information on how to buy Virpax Stock please use our How to Invest in Virpax Pharmaceuticals guide.

Latest Virpax Pharmaceuticals' Change In Cash Growth Pattern

Below is the plot of the Change In Cash of Virpax Pharmaceuticals over the last few years. It is Virpax Pharmaceuticals' Change In Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Virpax Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Change In Cash10 Years Trend
Very volatile
   Change In Cash   
       Timeline  

Virpax Change In Cash Regression Statistics

Arithmetic Mean(92,785)
Coefficient Of Variation(12,411)
Mean Deviation4,942,930
Median(124,870)
Standard Deviation11,515,644
Sample Variance132.6T
Range54.6M
R-Value(0.09)
Mean Square Error141.7T
R-Squared0.01
Significance0.76
Slope(226,205)
Total Sum of Squares1856.5T

Virpax Change In Cash History

2024-9.4 M
2023-9.9 M
2022-17.8 M
202136.8 M
202013.3 K
2019 -6834.0

About Virpax Pharmaceuticals Financial Statements

Virpax Pharmaceuticals investors use historical fundamental indicators, such as Virpax Pharmaceuticals' Change In Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Virpax Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Change In Cash-9.9 M-9.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Virpax Stock Analysis

When running Virpax Pharmaceuticals' price analysis, check to measure Virpax Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virpax Pharmaceuticals is operating at the current time. Most of Virpax Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Virpax Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virpax Pharmaceuticals' price. Additionally, you may evaluate how the addition of Virpax Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.